Cagrilintide
A long-acting amylin analog studied in metabolic research.
Overview
Cagrilintide is a synthetic long-acting analog of the hormone amylin. In research literature it is studied for its interactions with amylin and calcitonin receptors and appetite-regulation pathways. It is commonly referenced in metabolic research, frequently alongside GLP-1-class compounds.
Referenced research ranges
0.3–2.4 mg, once weekly — research protocols reference gradual titration across weeks
Reconstitution default
5 mg in 2 mL yields 2.5 mg/mL; a 0.3 mg reference dose is 0.12 mL (12 units on a U-100 syringe).
Storage
Store lyophilized vials refrigerated; refrigerate after reconstitution and protect from light.
Considerations
- An amylin-class analog, mechanistically distinct from the incretin compounds it is often studied beside.
- Long half-life, so research protocols reference once-weekly administration.
- Reconstituted peptide is temperature-sensitive and light-sensitive.
Log doses, get reminders, and run the calculator in PepSensei.
PepSensei is an educational reference tool only. Nothing in this library is medical advice, and none of it is intended to diagnose, treat, cure, or prevent any condition. All figures — including dose ranges, half-lives, and reconstitution examples — are commonly-cited values drawn from published research literature and are provided strictly for reference and general education in a research context. They are not protocols, recommendations, or instructions. Always consult a licensed medical professional before making any decision related to your health.